References
- The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 Guidelines for the management of arterial hypertension. Blood Press 2007; 16: 135–232
- Chobanian A. V., Bakris G. L., Black H. R., Cushman W. C., Green L. A., Izzo J. L., Jr., et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and treatment of High Blood Pressure: National High Blood Pressure education Program Coordinating Committee. JAMA 2003; 289: 2560–2572
- Brown B., Hall A. S. Renin‐angiotensin system modulation: The weight of evidence. Am J Hypertension 2005; 18: 127S–133S
- Neal B., MacMahon S., Chapman N., Blood Pressure Lowering Treatment Trialists'Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood‐pressure‐lowering drugs: Results of prospectively designed overviews of randomised trials. Lancet 2000; 356: 1955–1964
- Turnbull F., Blood Pressure Lowering Treatment Trialists'Collaboration. Effects of different blood pressure‐lowering regimens on major cardiovascular events: Results of prospectively designed overviews of randomised trials. Lancet 2003; 362: 1527–1535
- Turnbull F., Neal B., Algert C., Chalmers J., Chapman N., Cutler J., et al. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood pressure lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus. Arch Intern Med 2005; 165: 1410–1419
- Stults B., Jones R. E. Management of hypertension in diabetes. Diabetes Spectrum 2006; 19: 25–31
- Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO‐HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 2000; 355: 253–259
- Daly C. A., Fox K. M., Remme W. J., Bertrand M. E., Ferrari R., Simoons M. L., EUROPA Investigators. The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: Results from the PERSUADE substudy. Eur Heart J 2005; 1369–1378
- Fox K. M., EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease; Randomised, double‐blind, placebo‐controlled, multicentre trial (the EUROPA study). Lancet 2003; 362: 782–788
- Erdine S. How well is hypertension controlled in Europe?. J Hypertens 2000; 18: 1348–1349
- Hart P., Bakris G. Hypertension control rates: time for translation of guidelines into clinical practice. Am J Med 2003; 117: 62–64
- Svensson S., Kjellgren K. I., Ahlner J., Saljo R. Reasons for adherence with antihypertensive medication. Int J Cardiol 2000; 76: 157–163
- Hansson L., Lloyd A., Anderson P., Kopp Z. Excess morbidity and cost of failure to achieve targets for blood pressure control in Europe. Blood Press 2002; 11: 35–45
- Loyd A., Schmieder C., Marcahant N. Financial and health costs of uncontrolled blood pressure in the United Kingdom. Pharmacoeconomics 2003; 21: 33–41